Evidence map›Paper›PMID 31671075›Full record

ArticleThe Journal of clinical investigation2020

SDR9C7 catalyzes critical dehydrogenation of acylceramides for skin barrier formation.

Takuya Takeichi, Tetsuya Hirabayashi, Yuki Miyasaka, Akane Kawamoto, Yusuke Okuno, Shijima Taguchi, Kana Tanahashi, Chiaki Murase, Hiroyuki Takama, Kosei Tanaka and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Discovery of Dihydroxy-Ketone-Type Protein-Bound Ceramides as the Dominant Type in Human Stratum Corneum.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. A standardized approach to test missenseJID innovations : skin science from molecules to population health · 2026
    Article
  7. Article
  8. Palmoplantar Keratoderma: A Mechanism-Based Disease Classification.Clinical, cosmetic and investigational dermatology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Human genetic defects of sphingolipid synthesis.Journal of inherited metabolic disease · 2025
    Review
  15. Skin Lipid Barrier: Structure, Function and Metabolism.Allergy, asthma & immunology research · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Cell biology of protein-lipid conjugation.Cell structure and function · 2023
    Review
  20. The Roles of sPLABiomolecules · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 2 countries.

Takuya TakeichiDepartment of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Tetsuya HirabayashiLaboratory of Biomembrane, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Yuki MiyasakaDivision of Experimental Animals, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Akane KawamotoBiological Science Research Laboratories, Kao Corporation, Haga, Tochigi, Japan.
Yusuke OkunoMedical Genomics Center, Nagoya University Hospital, Nagoya, Japan.
Shijima TaguchiDivision of Dermatology, Mito Kyodo General Hospital, Mito, Ibaraki, Japan.
Kana TanahashiDepartment of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Chiaki MuraseDepartment of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Hiroyuki TakamaDepartment of Dermatology, Aichi Medical University, Nagakute, Japan.
Kosei TanakaAnalytical Science Research Laboratories, Kao Corporation, Haga, Tochigi, Japan.
William E BoeglinDepartments of Pharmacology and Biochemistry and.
M Wade CalcuttVanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, Tennessee, USA.
Daisuke WatanabeDepartment of Dermatology, Aichi Medical University, Nagakute, Japan.
Michihiro KonoDepartment of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yoshinao MuroDepartment of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Junko IshikawaBiological Science Research Laboratories, Kao Corporation, Haga, Tochigi, Japan.
Tamio OhnoDivision of Experimental Animals, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Alan R BrashDepartments of Pharmacology and Biochemistry and.
Masashi AkiyamaDepartment of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nagoya University · JPKao Corporation (Japan) · JPAichi Medical University · JPMito Saiseikai General Hospital · JPNagoya University Hospital · JPTokyo Metropolitan Institute of Medical Science · JPVanderbilt University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The corneocyte lipid envelope, composed of covalently bound ceramides and fatty acids, is important to the integrity of the permeability barrier in the stratum corneum, and its absence is a prime structural defect in various skin diseases associated with defective skin barrier function. SDR9C7 encodes a short-chain dehydrogenase/reductase family 9C member 7 (SDR9C7) recently found mutated in ichthyosis. In a patient with SDR9C7 mutation and a mouse Sdr9c7-KO model, we show loss of covalent binding of epidermal ceramides to protein, a structural fault in the barrier. For reasons unresolved, protein binding requires lipoxygenase-catalyzed transformations of linoleic acid (18:2) esterified in ω-O-acylceramides. In Sdr9c7-/- epidermis, quantitative liquid chromatography-mass spectometry (LC-MS) assays revealed almost complete loss of a species of ω-O-acylceramide esterified with linoleate-9,10-trans-epoxy-11E-13-ketone; other acylceramides related to the lipoxygenase pathway were in higher abundance. Recombinant SDR9C7 catalyzed NAD+-dependent dehydrogenation of linoleate 9,10-trans-epoxy-11E-13-alcohol to the corresponding 13-ketone, while ichthyosis mutants were inactive. We propose, therefore, that the critical requirement for lipoxygenases and SDR9C7 is in producing acylceramide containing the 9,10-epoxy-11E-13-ketone, a reactive moiety known for its nonenzymatic coupling to protein. This suggests a mechanism for coupling of ceramide to protein and provides important insights into skin barrier formation and pathogenesis.

Indexed as

AnimalsCatalysisCeramidesDisease Models, AnimalEpidermisGenetic Diseases, InbornHumansIchthyosisMiceMice, KnockoutOxidoreductasesCeramidesOxidoreductasesDermatologyGenetic diseasesMouse modelsSkin

Identifiers

PMID31671075
PMCPMC6994155
OpenAlexW2983181033

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.